Arcadia Biosciences, Inc. (17D.F)
- Previous Close
3.7200 - Open
3.7200 - Bid --
- Ask --
- Day's Range
3.7200 - 3.7200 - 52 Week Range
1.8000 - 7.4000 - Volume
378 - Avg. Volume
0 - Market Cap (intraday)
5.085M - Beta (5Y Monthly) 0.78
- PE Ratio (TTM)
-- - EPS (TTM)
-2.7800 - Earnings Date May 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
www.arcadiabio.com9
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 17D.F
View MorePerformance Overview: 17D.F
Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 17D.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 17D.F
View MoreValuation Measures
Market Cap
4.20M
Enterprise Value
612.61k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.14
Price/Book (mrq)
0.93
Enterprise Value/Revenue
0.14
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-139.50%
Return on Assets (ttm)
-28.06%
Return on Equity (ttm)
-45.62%
Revenue (ttm)
5.04M
Net Income Avi to Common (ttm)
-4.32M
Diluted EPS (ttm)
-2.7800
Balance Sheet and Cash Flow
Total Cash (mrq)
4.24M
Total Debt/Equity (mrq)
2.49%
Levered Free Cash Flow (ttm)
-1.39M